Given the role of ASXL1 in chromatin modification, we hypothesized that pathogenic ASXL1 variants underlying Bohring-Opitz syndrome (BOS) have a unique DNAm signature. The gene discussed is ASXL1; the disease is Bohring-Opitz syndrome.